Joseph Lind serves as Executive at Neuberger Berman High Yield Strategies Fund Inc., where they oversee executive responsibilities. Since joining the company, Joseph Lind has executed 6 insider transactions totaling $188.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 3, 2023 involved exercising options for 5,833 shares valued at $43.3K.
Joseph Lind currently holds 32,500 shares of Neuberger Berman High Yield Strategies Fund Inc. (NHS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph Lind has been a net buyer of NHS stock. They have purchased $188.3K and sold $0 worth of shares.
Joseph Lind's most recent insider trade was on Jul 3, 2023, when they sold 5,833 shares at $7.42 per share.
Get notified when new Form 4 filings are submitted
| $7.42 |
| Discretionary |
| Jun 7, 2022 | NHS | $45.7K | Purchase | 5,000 | $9.14 | Discretionary |
| Jun 6, 2022 | NHS | $46.3K | Purchase | 5,000 | $9.25 | Discretionary |
| May 17, 2022 | NHS | $43.0K | Exercise | 5,000 | $8.60 | Discretionary |
| Dec 27, 2018 | NHS | $96.3K | Purchase | 10,000 | $9.63 | Discretionary |